Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 01, 2018
Nitto Denko Avecia announced the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities.
read more
Tuesday, February 20, 2018
Ionis Pharmaceuticals has licensed IONIS-AZ5-2.5Rx (AZD2373) to AstraZeneca.
read more
Tuesday, February 27, 2018
Sherpa Clinical Packaging announced new Active Pharmaceutical Ingredient (API) sampling and storage services.
read more
Avid announced that Acumen has selected Avid to provide process development and clinical manufacturing services in support of ACU193.
read more
Grand River Aseptic Manufacturing expands its capabilities in syringe filling at its FDA-inspected, cGMP-compliant manufacturing facility in Grand Rapids, Mich.
read more
Wednesday, March 07, 2018
Pfizer CentreOne announced the introduction of Enviero progesterone into the API marketplace.
read more
Wednesday, March 14, 2018
Minakem has initiated the extension of its manufacturing capacity at its Dunkirk site in France.
read more
Ardena has acquired ChemConnection, a contract manufacturer of novel APIs and nanomedicines.
read more
Noramco and AFC announced a strategic partnership to produce certain US DEA controlled substances for use in the treatment of addiction, abuse prevention, cannabinoids for clinical indications, and ADHD.
read more
Dr. Reddy’s and its subsidiary, Promius Pharma announced the filing of NDA for its migraine candidate DFN-02 with the FDA.
read more
Evotec has launched its accelerated drug development service INDiGO.
read more
Sterling Pharma Solutions is investing £6m into its pilot plant facility at its UK site to enhance its scale-up and small to midscale commercial API manufacturing capabilities.
read more
Cambrex has completed the installation of multiple continuous flow reactor platforms at its High Point, NC facility.
read more
Codexis and Porton Pharma announce a collaboration to deploy Codexis’ biocatalyst technology within Porton’s global custom intermediate and API development and manufacturing business.
read more
Noramco and SPI Pharma have signed an agreement to develop and license a set of “value-added” formulation packages for global pharmaceutical manufacturers of finished dosage forms.
read more